Combined score of Y chromosome loss and T-cell infiltration improves UICC based stratification of esophageal adenocarcinoma

Verena Maria Raters(University of Cologne), Thomas Zander(Integrated Oncology (United States))

Frontiers in Oncology

November 17, 2023

10.3389/fonc.2023.1249172

Cited by 7

Related Papers

High-throughput oncogene mutation profiling in human cancer

|Nature Genetics|2007|996

Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer

|Proceedings of the National Academy of Sciences|2009|255

The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI

|BMC Cancer|2017|226

A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer

|Investigational New Drugs|2019|30